Understanding the Current Monkeypox Situation: A Public Health Emergency of International Concern

Welcome to our latest blog post where we delve into the ongoing developments surrounding monkeypox, now referred to as empo. As of August 14, 2024, the World Health Organization (WHO) has declared a public health emergency of international concern. In this article, we will explore the implications of this declaration, the current outbreak, and the importance of vaccination in controlling the spread of the virus.

Background on Monkeypox (Empo)

Monkeypox has been a topic of discussion since its outbreak in 2022. The virus is divided into two clades: clade 1 and clade 2. Clade 1 is endemic to Africa and is more infectious and deadly, with a case fatality rate of up to 10%. In contrast, clade 2, which affected the United States in 2022, had a much lower mortality rate of 0.1%. Currently, clade 1B is causing concern, especially in the Democratic Republic of Congo and surrounding countries.

The Current Situation

As of August 2024, the rise of clade 1B has been alarming, with an estimated 177,000 infections reported in Africa this year alone, marking a 160% increase from the previous year. The mortality rate has increased to approximately 3%, with a significant impact on children, who represent 70% of the cases. This alarming trend has prompted the declaration of a public health emergency to facilitate funding and resources for vaccination and containment efforts.

Why the Declaration Matters

The declaration serves several purposes:

• It mobilizes international resources and funding.
• It raises awareness about the outbreak and encourages swift action.
• It allows for regulatory flexibility to expedite vaccine distribution and administration.

Vaccination Efforts and Options

The WHO and African health authorities are seeking 10 million doses of the vaccine to combat the outbreak, requiring approximately $4 billion in funding. The U.S. has already pledged $10 million and sent 50,000 doses. The vaccination strategy has shifted, allowing for intradermal administration, which increases the number of doses available.

Types of Vaccines

There are two primary vaccines in use:

• AAM 2000: A live virus vaccine that requires multiple injections and is associated with higher side effects.
• Genos Vaccine: A newer, attenuated live virus vaccine that is administered intradermally, resulting in fewer side effects and easier administration.

Effectiveness of Vaccines

Recent studies indicate that the effectiveness of the Genos vaccine is approximately 66% after two doses. Despite this, vaccination is not a guarantee against infection, emphasizing the need for continued public health measures.

Recommendations for Vaccination

The CDC recommends the Genos vaccine for individuals at high risk, including:

• Men who have sex with men and have had multiple partners.
• Individuals with a history of sexually transmitted diseases.
• Healthcare workers exposed to orthopox viruses.

Conclusion

The current monkeypox outbreak represents a significant public health challenge that requires urgent attention. The declaration of a public health emergency highlights the need for international cooperation and resource allocation to control the spread of the virus. Effective vaccination strategies and public awareness are crucial in mitigating the impact of this infection.

Stay informed and take precautions to protect yourself and your community as we navigate this evolving situation.